ongo
outbreak
kill
twentyon
thousand
sicken
four
hundr
thousand
peopl
worldwid
pose
great
challeng
global
public
health
sensit
accur
diagnosi
method
substanti
help
control
diseas
expans
develop
chemiluminescenceimmunoassay
method
base
recombin
nucleocapsid
antigen
magnet
bead
diagnosi
infect
surveil
antibodi
chang
pattern
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
medrxiv
preprint
serolog
test
tool
diagnosi
infect
commun
serum
healthi
individu
tuberculosi
patient
confirm
patient
employ
evalu
perform
approach
compar
igm
test
igg
test
reliabl
identifi
infect
confirm
patient
two
falseposit
case
control
group
sensit
specif
reach
respect
howev
slight
differ
statist
signific
detect
case
infect
observ
igm
igg
test
manner
patient
differ
time
onset
diseas
perform
comparison
elisa
kit
use
nucleocapsid
antigen
chemiluminesc
method
undertaken
falseposit
case
seen
method
pair
control
group
elisa
kit
detect
half
infect
pair
confirm
patient
group
chemiluminesc
method
indic
higher
perform
chemiluminescenceimmunoassay
approach
togeth
studi
provid
use
valuabl
introduct
coronaviru
belong
famili
coronavirdia
order
nidoviral
group
envelop
nonseg
positivesens
rna
viru
report
abl
infect
human
wide
rang
anim
includ
cattl
swine
chicken
cat
hors
camel
rodent
bat
snake
forth
base
genet
properti
coronaviru
divid
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
four
genera
name
alphacoronaviru
betacoronaviru
gammacoronaviru
deltacoronaviru
prior
decemb
total
six
coronavirus
document
capabl
caus
diseas
human
includ
two
strain
alphacoronaviru
four
betacoronaviru
subfamili
sarscov
merscov
among
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
welldescrib
directli
led
two
deadli
largescal
outbreak
global
case
infect
roughli
percent
mortal
case
percent
mortal
respect
recent
outbreak
sever
pneumonia
confirm
caus
novel
coronaviru
infect
origin
seafood
wholesal
market
wuhan
china
far
novel
coronaviru
spread
throughout
whole
china
countri
global
caus
laboratoryconfirm
case
infect
peopl
dead
pose
great
threat
global
public
health
http
besid
still
numer
suspect
case
myriad
medic
monitor
peopl
quarantin
special
hospit
home
previou
epidemiolog
link
confirm
patient
put
extrem
burden
emerg
hospit
public
health
system
particularli
epidem
zone
worldwid
therefor
time
sensit
accur
diagnosi
approach
urgent
need
pivot
import
surveil
diseas
dissemin
prevent
expans
convent
diagnosi
method
viru
cultur
microscop
analysi
gener
timeconsum
laborintens
limit
sensit
contrast
last
decad
emerg
molecular
biolog
serolog
approach
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
taqman
realtim
revers
transcript
polymeras
chain
reaction
rtpcr
enzymelink
immunosorb
assay
colloid
gold
immunochromatographi
direct
chemiluminesc
immunoassay
clia
develop
rapid
effect
tool
detect
respiratori
pathogen
infect
even
though
certain
circumst
molecular
biolog
method
like
rtpcr
low
sensit
specimen
upper
respiratori
tract
studi
develop
chemiluminesc
immunoassay
method
specif
detect
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
length
nucleocapsid
antigen
express
engin
e
coli
strain
purifi
use
ninta
resin
darui
biotech
china
magnet
bead
use
studi
commerci
avail
jsr
corpor
tokyo
japan
recombin
nucleocapsid
antigen
coupl
tosyl
magnet
bead
use
catalyt
reagent
solut
ammonium
sulfat
borat
buffer
accord
manufactur
instruct
result
bead
block
bsa
six
hour
follow
test
detect
procedur
autom
chemic
immunoluminesc
analyz
tianshen
tech
shenzhen
china
compris
follow
step
microlit
pure
serum
firstli
incub
magnet
bead
coupl
antigen
minut
subsequ
unbound
substanc
gentli
remov
wash
tri
buffer
three
time
alkalin
phosphatas
label
antihuman
immunoglobulin
ad
incub
minut
me
buffer
three
time
wash
remov
unbound
materi
lumigen
substrat
eventu
ad
ultim
light
signal
measur
photomultipli
tianshen
tech
shenzhen
china
rel
light
unit
whole
test
complet
minut
confirm
positiveserum
negativeserum
use
control
set
test
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
firstli
coat
plate
respect
subsequ
dilut
serum
ad
incub
minut
five
time
wash
pbst
buffer
horseradish
peroxidas
hrp
label
mous
antihuman
igg
antibodi
hrplabel
squar
fisher
exact
test
use
compar
differ
analyz
group
differ
consid
signific
pvalu
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
assess
specif
sensit
chemiluminesc
immunoassay
method
develop
base
recombin
nucleocapsid
antigen
serum
healthi
individu
tuberculosi
patient
confirm
patient
employ
test
sixfold
eight
fold
higher
averag
rlu
rel
light
unit
valu
observ
patient
group
igm
test
compar
healthi
cohort
tuberculosi
patient
figur
tabl
contrast
use
igg
test
detect
two
falseposit
case
control
group
line
higher
specif
igg
compar
igm
test
describ
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
explor
whether
onset
time
significantli
link
detect
sensit
serolog
chemiluminesc
method
comparison
statist
analysi
sensit
rate
differ
onset
time
patient
categori
undertaken
statist
signific
differ
observ
igm
igg
test
result
patient
onset
time
although
two
case
case
detect
igm
test
compar
igg
test
patient
less
oneweek
onset
diseas
tabl
pvalu
stark
contrast
two
case
patient
identifi
igg
test
igm
test
patient
two
week
onset
diseas
pvalu
addit
also
compar
detect
rate
differ
age
group
peopl
found
significantli
lower
detect
rate
lgm
lgg
test
manner
individu
group
younger
year
old
observ
compar
peopl
age
pvalu
year
old
valu
supplementari
tabl
statist
signific
differ
observ
male
femal
group
well
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
igm
igg
test
manner
seen
chemiluminesc
method
suggest
higher
sensit
approach
compar
test
elisa
kit
tabl
singl
igg
test
feasibl
clinic
diagnosi
higher
specif
sensit
observ
chemiluminesc
method
humor
immun
respons
antibodi
igm
gener
produc
earlier
igg
isotyp
igm
express
without
isotyp
switch
unexpectedli
observ
slight
detect
rate
differ
statist
signific
two
antibodi
isotyp
test
manner
patient
first
week
two
week
onset
diseas
howev
compar
igg
approach
igm
method
show
lower
specif
higher
falseposit
case
test
igm
igg
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
use
pure
recombin
antigen
coupl
condit
supplementari
figur
detect
specif
differ
like
link
intrins
antibodi
trait
concentr
differ
patient
blood
note
four
patient
clinic
symptom
less
four
day
simultan
detect
igm
igg
test
close
examin
medic
record
reveal
previou
contact
confirm
individu
least
day
ago
point
possibl
probabl
asymptomat
infect
certain
time
alreadi
fourteen
case
confirm
patient
identifi
serolog
test
method
igm
igg
manner
interestingli
seven
peopl
younger
peopl
gener
low
immun
clinic
symptom
may
occur
rapidli
upon
exposur
specul
antibodi
peopl
may
develop
well
yet
test
investig
warrant
uncov
real
situat
compar
detect
rate
differ
age
group
method
note
significantli
lower
detect
rate
lgm
lgg
test
manner
individu
group
younger
year
old
observ
compar
peopl
age
indepth
look
day
onset
individu
younger
symptom
onset
time
peopl
less
day
six
peopl
even
less
seven
day
supplementari
tabl
lower
detect
rate
peopl
younger
like
associ
less
product
antibodi
yet
collect
serum
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
parallel
perform
test
antigen
nucleocapsid
protein
use
commerci
avail
elisa
kit
chemiluminesc
immunoassay
unexpectedli
significantli
higher
sensit
observ
method
compar
elisa
kit
sensit
differ
may
partial
attribut
differ
serum
amount
first
incub
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
tabl
evalu
chemiluminesc
immunoassay
method
diagnosi
detect
specif
igm
igg
patient
serum
